Ame Company For Medical Supplies
TADAWUL:9527.SR
118 (SAR) • At close May 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
| 2024 Q4 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| 18.808 | 26.593 | 13.296 | 11.319 | 5.659 | 22.197 | 11.307 | 15.377 | 13.725 | 7.498 |
| Depreciation & Amortization
| 0.878 | 0.947 | 0.473 | 0.824 | 0.412 | 0.711 | 0.478 | 0.375 | 0.314 | 0.145 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 0.062 | -44.82 | -22.4 | 1.594 | 1.333 | -6.662 | 9.58 | -27.22 | -10.941 | 3.064 |
| Accounts Receivables
| -2.868 | -24.582 | -7.347 | 3.808 | -0.074 | -17.165 | 17.798 | -18.093 | -4.81 | -8.249 |
| Change In Inventory
| -19.285 | -7.214 | -3.607 | -2.823 | -1.412 | 4.103 | -12.854 | -8.703 | -8.437 | 5.454 |
| Change In Accounts Payables
| 3.944 | 0.086 | 0 | 0.511 | 0 | 0 | -0.4 | 0.153 | -0.133 | 0.378 |
| Other Working Capital
| 18.271 | -13.11 | -11.446 | 0.097 | 2.818 | 6.4 | 5.036 | -0.576 | 2.44 | 5.48 |
| Other Non Cash Items
| -3.749 | -2.273 | -1.147 | 3.801 | 1.289 | 17.505 | -8.439 | 30.822 | 16.451 | 6.723 |
| Operating Cash Flow
| 15.999 | -19.554 | -9.777 | 17.386 | 8.693 | 19.266 | 16.514 | -8.04 | 5.541 | 14.723 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -0.445 | -0.06 | -0.03 | -0.39 | -0.195 | -1.544 | -0.088 | -0.727 | -0.298 | -0.037 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.076 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| -0.445 | -0.06 | -0.03 | -0.39 | -0.195 | -1.544 | -0.088 | -0.727 | -0.223 | -0.037 |
| Financing Activities: | ||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0.012 | -14 | -7 | 0 | 0 | -13.99 | 0 | -12.25 | 0 | -1.6 |
| Other Financing Activities
| -0.393 | -0.75 | -0.375 | -0.013 | -0.007 | -0.634 | -0.113 | -0.392 | -4.599 | -0.088 |
| Financing Cash Flow
| -0.382 | -14.75 | -7.375 | -0.013 | -0.007 | -14.624 | -0.113 | -12.642 | -4.599 | -1.688 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 0 | -34.363 | 0 | 16.983 | 0 | 3.098 | 16.313 | -21.408 | 0.72 | 12.997 |
| Cash At End Of Period
| 24.212 | 9.039 | 0 | 43.403 | 0 | 26.419 | 23.321 | 7.008 | 28.417 | 27.697 |